We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biomedical Engineers Reveal Organ-on-Chip Device for Drug Testing and Organ Repair

By LabMedica International staff writers
Posted on 21 Mar 2016
A soft, biodegradable polymer was used to form a three-dimensional organ-on-chip device for growth of artificial organs that could be used for drug testing or the repair or replacement of damaged organs.

Poly(octamethylene maleate (anhydride) citrate) (POMaC) is a soft, biodegradable elastomer with the potential to be a good biomaterial for use in scaffolds for soft tissue engineering. More...
POMaC is notable for its dual cross-linking mechanism that allows the engineer to manipulate the resultant mechanical properties of the material during preparation.

Investigators at the University of Toronto (Canada) used POMaC to fashion "AngioChip" scaffolds comprising a series of thin layers about 50 to 100 micrometers wide, stamped with a pattern of nanopore and micro-hole channels. The layers, which resembled computer microchips, were then stacked into a three-dimensional structure of synthetic blood vessels. The scaffold was bathed in media containing living cells. The cells rapidly attached to the inside and outside of the channels and began growing.

The investigators reported in the March 7, 2016, online edition of the journal Nature Materials that incorporation of nanopores and micro-holes in the vessel walls enhanced permeability, and permitted intercellular crosstalk and extravasation of monocytes and endothelial cells on biomolecular stimulation. They also showed that vascularized hepatic tissues and cardiac tissues engineered by using AngioChips processed clinically relevant drugs delivered through the vasculature, and that millimeter-thick cardiac tissues could be engineered in a scalable manner. Furthermore, AngioChip cardiac tissues implanted into the femoral vessels of rat hindlimbs established immediate blood perfusion.

"It is a fully three-dimensional structure complete with internal blood vessels," said senior author Dr. Milica Radisic, professor of biomedical engineering at the University of Toronto. "It behaves just like vasculature, and around it there is a lattice for other cells to attach and grow. Previously, people could only do this using devices that squish the cells between sheets of silicone and glass. You needed several pumps and vacuum lines to run just one chip. Our system runs in a normal cell culture dish, and there are no pumps; we use pressure heads to perfuse media through the vasculature. The wells are open, so you can easily access the tissue. Our liver actually produced urea and metabolized drugs."

Related Links:

University of Toronto



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automatic CLIA Analyzer
Shine i6000
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.